A proprietary formulation of bupivacaine with meloxicam, developed by Heron Therapeutics, relieves acute pain for 72 hours after surgery.
FDA
Posted inAutoimmune Diseases, Neuroscience, New Drugs, Regulatory
Zeposia: New Drug to Treat Relapsing Multiple Sclerosis
Bristol-Myers Squibb has come up with ozanimod, a direct competitor to Novartis’ fingolimod and siponimod, for the treatment of multiple sclerosis.
Posted inOncology, Regulatory
Opdivo and Keytruda: First-line Immunotherapy for Gastric Cancer and Esophageal Cancer
Nivolumab or pembrolizumab should be added to standard chemotherapy to prolong the life of patients with gastric, esophageal, and gastroesophageal junction cancers.
Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory
Danyelza: New Drug for Neuroblastoma That Can Cure It
Naxitamab by Y-mAbs Therapeutics offers gorgeous treatment efficacy with unsafe adverse events.
Posted inNew Drugs, Rare/Orphan Diseases, Regulatory
Koselugo: First Drug to Treat Neurofibromatosis
Selumetinib by AstraZeneca powerfully suppresses tumor growth in neurofibromatosis type 1.
Posted inNeuroscience, New Drugs, Regulatory
Reyvow: Completely New Drug for Acute Treatment of Migraine
In the task of getting rid of headaches lasmiditan by Eli Lilly is as effective as the popular triptans, but safer.
Posted inNeuroscience, New Drugs, Rare/Orphan Diseases, Regulatory
Zolgensma: Gene Therapy That Cure Spinal Muscular Atrophy. The Most Comprehensive Review
Novartis revealed the most expensive drug in the world. And it is amazing.